Valeria P.
- Country
- The Netherlands
- Department
- N/A
Research Overview
- Evaluation of Bosentan in the Management of Coronary Vasospasm: A Randomized Controlled Trial
- Evaluation of Evolocumab on Cardiovascular Outcomes in High-Risk Patients Without Prior Myocardial Infarction or Stroke
- Evaluation of Diltiazem Hydrochloride on Coronary Microvascular Dysfunction in Symptomatic Angina Patients: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 79 of 533 partner sites.
Specializations
Coronary Vascular Disorders
The investigator specializes in treating coronary vasospasm and coronary vasomotor dysfunction, with particular focus on therapeutic interventions for patients experiencing ongoing angina symptoms.
- Endothelin receptor antagonism therapy
- Coronary function testing
- Microvascular dysfunction management
Research extends to evaluating novel treatment approaches for coronary microvascular disorders using calcium channel blockers.
Interventional Cardiology
Expertise in percutaneous coronary intervention (PCI) with specific interest in optimizing antithrombotic therapy through genetic-guided approaches.
- Personalized antiplatelet therapy
- Post-PCI medication management
- OCT-guided revascularization
Focus includes developing tailored approaches for patients requiring both anticoagulation and antiplatelet therapy.
Structural Heart Disease
Active involvement in treating calcific aortic valve stenosis through innovative therapeutic approaches targeting lipoprotein metabolism.
- Aortic valve disease progression
- Novel therapeutic interventions
- Cardiovascular imaging applications
Research encompasses both echocardiographic and computed tomography assessment of disease progression.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.